Multiple reaction monitoring assay based on conventional liquid chromatography and electrospray ionization for simultaneous monitoring of multiple cerebrospinal fluid biomarker candidates for Alzheimer’s disease-Reference-Cited by-同舟云学术

Multiple reaction monitoring assay based on conventional liquid chromatography and electrospray ionization for simultaneous monitoring of multiple cerebrospinal fluid biomarker candidates for Alzheimer’s disease

Published:2015-09-24 Issue:3 Volume:39 Page:390-397
ISSN:0253-6269
Container-title:Archives of Pharmacal Research
language:en
Short-container-title:Arch. Pharm. Res.

Author:

Choi Yong Seok,Lee Kelvin H.

Funder

The National Institutes of Health (US)

The New York State Office of Sciecne, Technology, and Academic Research

The Institute for the Study of Aging

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12272-015-0663-y.pdf

Reference27 articles.

1. Abdi, F., J.F. Quinn, J. Jankovic, M. McIntosh, J.B. Leverenz, E. Peskind, R. Nixon, J. Nutt, K. Chung, and C. Zabetian. 2006. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. Journal of Alzheimer’s Disease 9: 293–348.

2. Alzheimer’s Association. 2014 Alzheimer’s disease facts and figures. [Online] Available from http://www.alz.org/downloads/Facts_Figures_2014.pdf . Accessed 30 June 2015.

3. Anderson, L., and C.L. Hunter. 2006. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Molecular & Cellular Proteomics 5: 573–588.

4. Arnold, S.E., B.T. Hyman, J. Flory, A.R. Damaiso, and G.W. Van Hoesen. 1991. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cerebral cortex 1: 103–116.

5. Carrette, O., I. Demalte, A. Scherl, O. Yalkinoglu, G. Corthals, P. Burkhard, D.F. Hochstrasser, and J.C. Sanchez. 2003. A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer’s disease. Proteomics 3: 1486–1494.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimized method development and validation for determining donepezil in rat plasma: A liquid-liquid extraction, LC-MS/MS, and design of experiments approach;PLOS ONE;2024-09-06

2. FGF9 is required for Purkinje cell development and function in the cerebellum;iScience;2024-02

3. FGF9 Is Required for Purkinje Cell Development and Function in the Cerebellum;2023

4. APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid;Journal of Alzheimer's Disease;2021-01-19

5. APOE4 Copy Number-Dependent Proteomic changes in the Cerebrospinal Fluid;2020-07-02